Glenmark Pharmaceuticals Ltd AGM

Glenmark Pharma Appoints Anurag Mantri as New CFO

 Copy Link

The reshuffle comes after VS Mani, the company's current chief, announced early retirement; he will officially retire as chief on May 26, 2025 after an eight-year career with the company.

Glenmark Gets USFDA Nod for Olopatadine Ophthalmic Solution

 Copy Link

This approval would allow Glenmark Therapeutics Inc., USA to market the product in the US market and would further fortify its ophthalmic portfolio.

Glenmark Expands US Portfolio with Acetylcysteine Injection Launch

 Copy Link

Acetylcysteine Injection will be launched in 6 gm/30 mL (200 mg/mL) single-dose vials, and will be made available to hospitals and other system-wide healthcare providers.

Glenmark Pharma Settles US Legal Dispute Over Generic Zetia

 Copy Link

The lawsuits included one on a generic version of Zetia, a cholesterol drug, as well as four other lawsuits involving Vytorin, a combination drug that contains Zetia.

Glenmark Pharma Q3 Revenue Jumps 35% to ₹3,388 Crore

 Copy Link

EBITDA surged to ₹600.3 crore, up from a loss of ₹208.7 crore in the year-ago quarter, indicating better operational efficiency

Glenmark Hit with ₹121.25 Crore Tax Demand, Company to Appeal

 Copy Link

It also appropriates ₹5.86 crore that Glenmark had already paid for surrendering IGST refunds relating to non-realisation of export proceeds.

Glenmark Launches Generic Glaucoma Drug

 Copy Link

According to a statement from the firm, the Travoprost ophthalmic solution (0.004% ionic buffered solution) is both bioequivalent and therapeutically equivalent to the reference listed medication

Glenmark Pharmaceuticals Posts ₹354.4 Crore Profit in Q2

 Copy Link

The company also reported revenue from operations to ₹3433.7 Crore. The EBITDA margin for the quarter that ended on September 30, 2024 stands at 17.5%.

Glenmark Recalls US Products Over Manufacturing Issues

 Copy Link

Glenmark Pharmaceuticals Inc, USA, issued a countrywide (US) Class II recall on September 24 this year.

Glenmark Pharmaceuticals' Aurangabad Facility Passes FDA Inspection

 Copy Link

This positive outcome indicates compliance with FDA standards and enhances Glenmark's credibility in the pharmaceutical sector.